- Analysis by McKinsey Health Institute shows that improving metabolic health could significantly improve health outcomes and unlock positive economic impact globally
- The analysis highlights the need for an aspirational vision and the design of a comprehensive program of interventions, which include success factors such as, local leadership, cross-sector collaboration, and strong role modelling
- In Abu Dhabi, preventing obesity is a whole-of-government priority, underscored by the establishment of the Healthy Living Unit – an effort that seeks to become the global reference case for ensuring population-wide metabolic health
Abu Dhabi, UAE, 16 April 2025: During Abu Dhabi Global Health Week (ADGHW), the Abu Dhabi Public Health Centre (ADPHC), established to ensure a public health system that maintains the health of the population in the Emirate, and the McKinsey Health Institute, an enduring institute inside McKinsey & Co. dedicated to adding life to years and years to life, unveiled analysis exploring the success factors and lessons learned when implementing metabolic health programs in Abu Dhabi.
The publication presents a data-driven analysis of adult metabolic health and intervention strategies, and offers a roadmap for the global health community to address these interconnected challenges at scale. Its insights include:
- The global scale of obesity – and Abu Dhabi’s approach to advancing metabolic health: Obesity is a growing global issue, affecting more than 40% of the population in some high-income countries, including the US, and rising fast in low-and-middle-income countries. It is deeply interconnected with various factors, and targeting weight alone risks overlooking complex, interconnected drivers. Abu Dhabi is seeking to become the global reference case for tackling metabolic health at scale, and the white paper includes insights into the comprehensive approach pioneered by the Emirate to advance metabolic health.
- The case for improving metabolic health vs preventing obesity only: The paper explores a broader and more systemic approach to advancing metabolic health across multiple indicators. Taking this comprehensive approach may unlock 3.5x more healthy life years than targeting obesity alone. It could also eventually lead to a multi-trillion-dollar gross domestic product (GDP) uplift by 2050.
- The blueprint for setting a metabolic health strategy: Significant population-level impact is possible, and requires setting an aspirational vision and designing a comprehensive program of interventions. The paper explores successful case studies, and charts the key success factors for delivering interventions, including local leadership and long-term commitment, cross-sector collaboration, and strong role modelling.
Dr. Panco Georgiev, Senior Partner from McKinsey & Company, said: “The McKinsey Health Institute (MHI) has the mission to catalyse the actions needed across continents, sectors, and communities to unlock the potential of adding as much as 45 billion extra years of higher-quality life over the next decade. Improving metabolic health is crucial for realising this possibility. This white paper offers tangible, scalable solutions and we are excited to see Abu Dhabi pioneering a scalable model to inform global health strategies.”
By uniting policy, technology, and clinical leadership, the paper provides a practical guide for governments and health systems. With metabolic disorders impacting over 1 billion people globally, it offers a replicable model for international implementation. Abu Dhabi, through its comprehensive framework, aims to provide a case study of global health best practices by catalysing collaboration and innovation in one of today’s most urgent health domains.
-ENDS –
About Abu Dhabi Global Health Week:
Abu Dhabi Global Health Week (ADGHW) is a major government-led initiative by the Department of Health – Abu Dhabi (DoH). It drives transformative innovation and collaboration under the theme ‘Towards Longevity: Redefining Health and Well-being’. ADGHW serves as a year-round ‘always-on’ platform with a proactive approach centred around preventive, personalised, and holistic care. Held with and for the world, ADGHW is a platform for open, inclusive exchange, and joint action.
ADGHW welcomes entrepreneurs, policymakers, researchers, innovators, and investors to transform ideas into action, and collaborate around topics like advancing precision care and building a resilient technology-driven ecosystem. ADGHW 2025 proudly collaborates with key strategic partners, including Foundation Partner, M42 and Global Health and Longevity Champion, PureHealth. Additional exhibitors and sponsors include Burjeel, GSK, Johnson & Johnson, Lilly, Microsoft, Novo Nordisk, Viatris, Novartis, Roche, Cleveland Clinic Abu Dhabi, Deloitte, Gilead, Juvenescence, NYU Abu Dhabi and Pfizer, united in their commitment to advancing the future of healthcare and life sciences.
For more information on ADGHW, visit https://www.adghw.com/
For media registration visit, https://www.adghw.com/forms/media-registration/